The global vascular guidewires market size in 2017 is $883 million, and is projected to reach $1,336 million by 2025, growing at a CAGR of 5.4% from 2018 to 2025.
A guidewire is a long and flexible spring that assists the introduction and placement of implantable medical devices into a patients body. Vascular guidewires are used during various interventional cardiology procedures (including placement of angioplasty balloons, stents, inferior vena cava filters, and others) as they guide a surgeon for the correct placement of these devices.
There is an increase in the demand for vascular guidewires due to rise in the prevalence of cardiovascular disorders, increase in geriatric population, demand for minimally invasive procedures, and rapid technological advancements in guidewires drive the market growth. However, risks and complications associated with guidewires, and availability of effective conventional treatment options restrict the market growth. Conversely, increase in use of nitinol in vascular guidewires and growth opportunities in the emerging economies of the Asia-Pacific and LAMEA are expected to provide several opportunities for market growth during the forecast period.
The vascular guidewires market is segmented based on application, coating type, end user, and region. Based on product, the market is segmented into coronary guidewires and peripheral guidewires. Depending on coating type, the market is categorized into coated and non-coated. Coated segment is further bifurcated into hydrophilic coating and hydrophobic coating. Based on end user, the market is segmented into hospitals and ambulatory surgical centers. Based on region, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2025, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the global vascular guidewires market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS
By Application
o Coronary Guidewires
o Peripheral Guidewires
o Urology Guidewires
o Neurovascular Guidewires
By Coating Type
o Coated
Hydrophilic Coating
Hydrophobic Coating
o Non-Coated
By End User
o Hospitals
o Ambulatory Surgical Centers (ASCs)
By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
UK
Italy
Spain
Rest of Europe
o Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
o LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
KEY MARKET PLAYERS
Abbott Laboratories
B. Braun Melsungen AG
Becton, Dickinson and Company (C.R. Bard)
Biotronik SE & Co. KG
Boston Scientific Corporation
Cardinal Health, Inc.
Cook Medical Inc.
Olympus Corporation
Terumo Corporation
The other players in the value chain include (profiles not included in the report):
Stryker Corporation
Teleflex Incorporated
AngioDynamics
Asahi Intecc USA, Inc.
Bard Peripheral Vascular, Inc.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings
2.1.1. Top impacting factors
2.1.2. Top investment pockets
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Parent Market Overview
3.3. Key Forces Shaping Vascular Guidewires Market
3.3.1. Moderate bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. High bargaining power of buyers
3.4. Pricing Analysis
3.4.1. Pricing Analysis, By Region, 2018 & 2025
3.5. Value Chain Analysis
3.6. Impact of government regulations on global vascular guidewires market
3.7. Industry Pain point analysis
3.8. Patent Analysis
3.8.1. Patent analysis, by year
3.8.2. By Region (2016-2018)
3.8.3. By Applicant
3.9. Case Studies
3.9.1. Case Study 01
3.10. Market dynamics
3.10.1. Drivers
3.10.1.1. Increase in incidence of cardiac disorders and growth in geriatric population
3.10.1.2. Rise in patient awareness
3.10.1.3. Presence of high unmet medical needs
3.10.2. Restraints
3.10.2.1. Risks and complications associated with guidewires
3.10.2.2. Preference for drugs over treatment devices
3.10.3. Opportunities
3.10.3.1. Use of nitinol in vascular guidewires
CHAPTER 4: VASCULAR GUIDEWIRES MARKET, BY APPLICATION
4.1. Overview
4.2. Market size and forecast
4.3. Coronary guidewires
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis by country
4.4. Peripheral guidewires
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis by country
4.5. Urological Guidewires
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis by country
4.6. Neurovascular Guidewires
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis by country
CHAPTER 5: VASCULAR GUIDEWIRES MARKET, BY COATING TYPE
5.1. Overview
5.2. Market size and forecast
5.3. Coated
5.3.1. Market size and forecast, by type
5.3.1.1. Hydrophilic coating
5.3.1.1.1. Market size and forecast
5.3.1.2. Hydrophobic coating
5.3.1.2.1. Market size and forecast
5.3.2. Market size and forecast, by region
5.3.3. Market analysis by country
5.4. Non-Coated
5.4.1. Market size and forecast, by region
5.4.2. Market analysis by country
CHAPTER 6: VASCULAR GUIDEWIRES MARKET, BY END USER
6.1. Overview
6.2. Market size and forecast
6.3. Hospitals
6.3.1. Market size and forecast, by region
6.3.2. Market analysis by country
6.4. Ambulatory surgical centers (ASCs)
6.4.1. Market size and forecast, by region
6.4.2. Market analysis by country
CHAPTER 7: VASCULAR GUIDEWIRES MARKET, BY REGION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. North America vascular guidewires market, by country
7.2.2.1. U.S. vascular guidewires market by application
7.2.2.2. U.S. vascular guidewires market by coating type
7.2.2.3. U.S. vascular guidewires market by end user
7.2.2.4. Canada vascular guidewires market by application
7.2.2.5. Canada vascular guidewires market by coating type
7.2.2.6. Canada vascular guidewires market by end user
7.2.2.7. Mexico vascular guidewires market by application
7.2.2.8. Mexico vascular guidewires market by coating type
7.2.2.9. Mexico vascular guidewires market by end user
7.2.3. North America vascular guidewires market, by application
7.2.4. North America vascular guidewires market, by coating type
7.2.5. North America vascular guidewires market, by end user
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Europe vascular guidewires market, by country
7.3.2.1. Germany vascular guidewires market by application
7.3.2.2. Germany vascular guidewires market by coating type
7.3.2.3. Germany vascular guidewires market by end user
7.3.2.4. France vascular guidewires market by application
7.3.2.5. France vascular guidewires market by coating type
7.3.2.6. France vascular guidewires market by end user
7.3.2.7. Spain vascular guidewires market by application
7.3.2.8. Spain vascular guidewires market by coating type
7.3.2.9. Spain vascular guidewires market by end user
7.3.2.10. Italy vascular guidewires market by application
7.3.2.11. Italy vascular guidewires market by coating type
7.3.2.12. Italy vascular guidewires market by end user
7.3.2.13. UK vascular guidewires market by application
7.3.2.14. UK vascular guidewires market by coating type
7.3.2.15. UK vascular guidewires market by end user
7.3.2.16. Rest of Europe vascular guidewires market by application
7.3.2.17. Rest of Europe vascular guidewires market by coating type
7.3.2.18. Rest of Europe vascular guidewires market by end user
7.3.3. Europe vascular guidewires market, by application
7.3.4. Europe vascular guidewires market, by coating type
7.3.5. Europe vascular guidewires market, by end user
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Asia-Pacific vascular guidewires market, by country
7.4.2.1. Australia vascular guidewires market by application
7.4.2.2. Australia vascular guidewires market by coating type
7.4.2.3. Australia vascular guidewires market by end user
7.4.2.4. Japan vascular guidewires market by application
7.4.2.5. Japan vascular guidewires market by coating type
7.4.2.6. Japan vascular guidewires market by end user
7.4.2.7. India vascular guidewires market by application
7.4.2.8. India vascular guidewires market by coating type
7.4.2.9. India vascular guidewires market by end user
7.4.2.10. China vascular guidewires market by application
7.4.2.11. China vascular guidewires market by coating type
7.4.2.12. China vascular guidewires market by end user
7.4.2.13. South Korea vascular guidewires market by application
7.4.2.14. South Korea vascular guidewires market by coating type
7.4.2.15. South Korea vascular guidewires market by end user
7.4.2.16. Rest of Asia-Pacific vascular guidewires market by application
7.4.2.17. Rest of Asia-Pacific vascular guidewires market by coating type
7.4.2.18. Rest of Asia-Pacific vascular guidewires market by end user
7.4.3. Asia-Pacific vascular guidewires market, by application
7.4.4. Asia-Pacific vascular guidewires market, by coating type
7.4.5. Asia-Pacific vascular guidewires market, by end user
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. LAMEA vascular guidewires market, by country
7.5.2.1. Brazil vascular guidewires market by application
7.5.2.2. Brazil vascular guidewires market by coating type
7.5.2.3. Brazil vascular guidewires market by end user
7.5.2.4. Saudi Arabia vascular guidewires market by application
7.5.2.5. Saudi Arabia vascular guidewires market by coating type
7.5.2.6. Saudi Arabia vascular guidewires market by end user
7.5.2.7. South Africa vascular guidewires market by application
7.5.2.8. South Africa vascular guidewires market by coating type
7.5.2.9. South Africa vascular guidewires market by end user
7.5.2.10. Rest of LAMEA vascular guidewires market by application
7.5.2.11. Rest of LAMEA vascular guidewires market by coating type
7.5.2.12. Rest of LAMEA vascular guidewires market by end user
7.5.3. LAMEA vascular guidewires market, by application
7.5.4. LAMEA vascular guidewires market, by coating type
7.5.5. LAMEA vascular guidewires market, by end user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Market Share Analysis of Top Players, 2018 (%)
8.3. Product Mapping of Top 10 Player
CHAPTER 9: COMPANY PROFILES:
9.1. Abbott Laboratories
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Business performance
9.2. B. Braun Melsungen AG
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance
9.3. Becton, Dickinson and Company (C.R. Bard)
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance
9.4. Biotronik SE & Co. KG
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Key strategic moves and developments
9.5. Boston Scientific Corporation
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.5.6. Key strategic moves and developments
9.6. Cardinal Health, Inc.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance
9.6.6. Key strategic moves and developments
9.7. Cook Medical Inc.
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.8. Medtronic Plc. (Covidien Ltd.)
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance
9.9. Olympus Corporation
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.10. Terumo Corporation
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance